W.R. Grace & Co. (GRA) Said Near Deal for Albemarle (ALB) Chemistry Arm - Bloomberg
- Wall St gains on bright earnings, megacaps' support
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil falls back after robust EU data as Mideast tensions linger
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- Apple, PepsiCo, JetBlue fall premarket; Amazon, GM and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
Grace (GRA) Expands Fast Growing Pharma Portfolio through Acquisition of Fine Chemistry Business
February 25, 2021 5:46 PM ESTW. R. Grace & Co. (NYSE: GRA, the Company) today announced that it has entered into a definitive agreement to acquire the Fine Chemistry Services business (FCS) of Albemarle Corporation (NYSE: ALB) for approximately $570 million, including $300 million paid in cash at closing and $270 million funded through the issuance to Albemarle of non-participating preferred equity of a newly created Grace subsidiary.
The acquisition significantly strengthens and expands Graces existing pharma portfolio. Pharma & Consumer is the largest, fastest growing and most profitable subsegment within Graces Materials Technologies business. FCS adds a comprehensive portfolio of high-value products... More
Albemarle (ALB) Confirms Deal to Sell Fine Chemistry Services Business to W.R. Grace & Co (GRA)
February 25, 2021 5:45 PM ESTAlbemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, today announced that it has signed a definitive agreement to sell its Fine Chemistry Services business to W.R. Grace & Co. for approximately $570 million, consisting of $300 million in cash, and the... More